<DOC>
	<DOCNO>NCT00574197</DOCNO>
	<brief_summary>Mycophenolate sodium ( Myfortic® ) newly develop enteric-coated tablet version mycophenolate mofetil ( Cellcept® ) currently use therapy prevention transplant rejection . Myfortic® develop improve gastrointestinal tolerability Cellcept® . The new enteric-coated , Myfortic® presently FDA approve prevention acute kidney rejection . There clinical data use heart transplant patient .</brief_summary>
	<brief_title>Enteric-coated Mycophenolate Sodium ( Myfortic® ) Heart Transplant Recipients</brief_title>
	<detailed_description>This open-labeled , prospective , non-randomized pilot-phase study enteric-coated , Myfortic® versus non enteric-coated , Cellcept® patient within 5 year undergone heart transplant surgery currently take Cellcept® . After initial screening , 20 patient fulfill inclusion criterion report symptom gastrointestinal side-effects take Cellcept switch Myfortic . All 20 patient follow closely period 6 month follow enrollment . Concomitant immunosuppressive therapy continue patient per standard treatment protocol .</detailed_description>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>1 . Patients either sex age 18 undergone successful orthotopic heart transplant surgery . 2 . Patients currently take Cellcept® experience gastrointestinal sideeffects standard therapy . 3 . Individuals Cellcept® total dosage 2 mg day less would eligible participate . 4 . Patients able give write informed consent . 1 . Patients absolute neutrophil count &lt; 1500 cells/mm3 , and/or leukocytopenia ( &lt; 2500 cells/mm3 ) , thrombocytopenia ( &lt; 75,000 cells/mm3 ) significant anemia ( hemoglobin &lt; 6g/dl ) time potential enrollment . 2 . Women childbearing potential use contraception method ( ) , well woman breastfeed . 3 . Known sensitivity study drug class study drug . 4 . Patients severe medical condition ( ) view investigator prohibit participation study . 5 . Use investigational agent last 30 day .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>Heart Transplant</keyword>
	<keyword>gastrointestinal</keyword>
	<keyword>Cellcept</keyword>
	<keyword>Myfortic</keyword>
	<keyword>GI</keyword>
	<keyword>GI symptom Mycophenolate Mofetil heart transplant</keyword>
</DOC>